Ellevest, Inc. Atreca, Inc. Transaction History

Ellevest, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$1.56 - $3.25 $492 - $1,027	316 New	316 $1,000
Q1 2022 Apr 19, 2022	SELL	$1.61 - $5.2 $227 - $733	-141 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$2.87 - $6.29 $404 - $886	141 New	141 $0

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.